Sort
1,049,261 grants matching “t cell”
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
Asthma Inflammation Research
$2,731,369Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL
Combinatorial Regulation of Gene Networks During Cardiac Development and Disease
$2,731,195Deepak Srivastava · J. David Gladstone Institutes · P01 · FY2020 · HL
Adjuvant Discovery for Vaccines against Influenza Virus
$2,730,922Ofer Levy · Boston Children'S Hospital · N01 · FY2018 · AI
The Midwest Child Patient Reported Outcomes (M-cPROs) Consortium
$2,730,837Julie A. Panepinto · Medical College Of Wisconsin · U19 · FY2015 · AR
Center for the Spatiotemporal Modeling of Cell Signaling (STMC)
$2,730,711Bridget S Wilson · University Of New Mexico · P50 · FY2012 · GM
Structural Basis of Biological Membrane Protein Functions and Drug Resistance
$2,730,568Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Plasticity circuits in Alzheimer s disease
$2,730,368Orly Lazarov · University Of Illinois At Chicago · RF1 · FY2020 · AG
Odor trail tracking: a new paradigm to unveil algorithms and neural circuits underlying active sensation and continuous decision making
$2,730,261Venkatesh N Murthy · Harvard University · RF1 · FY2022 · NS
iTarget: Institute for Biomolecular Targeting
$2,730,000Dean R Madden · Dartmouth College · P20 · FY2016 · GM
tRNA in codon usage
$2,730,000Ya-Ming Hou · Thomas Jefferson University · R35 · FY2025 · GM
SPORE IN BREAST CANCER
$2,729,995Northwestern University · P50 · FY2001 · CA
Systems Biology of Diversity in Cancer
$2,729,985Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
A TOLERANCE APPROACH TO XENOTRANSPLANTATION
$2,729,837David H Sachs · Massachusetts General Hospital · P01 · FY2008 · AI
Capacitative Calcium Entry
$2,729,741James W Putney · Environmental Health Sciences · Z01 · FY2007 · ES
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
$2,728,790Philip L De Jager · Columbia University Health Sciences · U01 · FY2022 · AG
Mechanisms of immune Failure in Chronic Infection: Hepatitis C as a Key Paradigm
$2,728,785Raymond T Chung · Massachusetts General Hospital · U19 · FY2013 · AI
Oxytocin Modulation of Neural Circuit Function and Behavior
$2,728,752Richard W Tsien · New York University School Of Medicine · U19 · FY2021 · NS
Microglia are necessary for cortical plaque formation in Alzheimer's disease
$2,728,590Kim Green · University Of California-Irvine · RF1 · FY2018 · AG
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,728,503Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2021 · HL
Anatomical characterization of neuronal cell types of the mouse brain
$2,728,264Hong-Wei Dong · University Of Southern California · U01 · FY2018 · MH
Assays to Support Development of Malaria Transmission Blocking Vaccines
$2,728,182Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Autism Genetics, Phase II: Increasing Representation of Human Diversity
$2,728,166Daniel H Geschwind · University Of California Los Angeles · R01 · FY2014 · MH
Dnmt3a as an epigenetic target for chronic pain treatment
$2,728,155Zhizhong Z Pan · University Of Tx Md Anderson Can Ctr · RF1 · FY2019 · NS
Models and Gene Therapies for AAT Deficiency
$2,728,017Terence R. Flotte · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · HL